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Summary
The etiology of progression from steatosis to steatohepatitis (SH) remains unknown. Using nutritional and geneticmodels of
hepatic steatosis, we show that free cholesterol (FC) loading, but not free fatty acids or triglycerides, sensitizes to TNF- and
Fas-induced SH. FC distribution in endoplasmic reticulum (ER) and plasma membrane did not cause ER stress or alter TNF
signaling. Rather, mitochondrial FC loading accounted for the hepatocellular sensitivity to TNF due to mitochondrial gluta-
thione (mGSH) depletion. Selective mGSH depletion in primary hepatocytes recapitulated the susceptibility to TNF and Fas
seen in FC-loaded hepatocytes; its repletion rescued FC-loaded livers from TNF-mediated SH. Moreover, hepatocytes from
mice lacking NPC1, a late endosomal cholesterol trafficking protein, or from obese ob/ob mice, exhibited mitochondrial FC
accumulation, mGSH depletion, and susceptibility to TNF. Thus, we propose a critical role for mitochondrial FC loading in
precipitating SH, by sensitizing hepatocytes to TNF and Fas through mGSH depletion.Introduction
Steatohepatitis (SH) represents an advanced stage in the spec-
trum of fatty liver disease that encompasses alcoholic (ASH) and
nonalcoholic steatohepatitis (NASH), two of the most common
forms of liver disease worldwide. Although the primary etiology
of ASH and NASH is different, these two diseases show almost
identical histology characterized by steatosis (macrovesicular >
microvesicular), mixed lobular inflammation with scattered PMN
leukocytes andmononuclear cells, and hepatocellular cell death
due to sensitivity to oxidative stress (Angulo, 2002; Feldstein
and Gores, 2005; Tilg and Diehl, 2000). Although fibrosis (gener-
ally in zone 3) and other signs, such as occasional acidophil bod-
ies, are not necessary for diagnosis, their presence reflects SH
progression (Brunt, 2004). In addition to alcohol or acetaldehyde
(Lluis et al., 2003; You andCrabb, 2004) and insulin resistance or
hyperinsulinemia (Angulo, 2002; Browning and Horton, 2004;
Horton et al., 2002), which promote the hepatic lipid accumula-
tion seen in ASH and NASH, respectively, hyperhomocysteine-
mia (Ji and Kaplowitz, 2004; Werstuck et al., 2001; Woo et al.,
2005) or antiretroviral therapy (Riddle et al., 2001; Williams
et al., 2004) stimulate de novo lipid synthesis and hepatic stea-
tosis. The causes for enhanced lipogenesis in these conditions
are complex, with the activation of membrane-bound transcrip-
tion factors SREBP-1c and SREBP-2 playing a prominent role
in the synthesis of free fatty acids (FFA) and cholesterol, respec-
tively (Brown and Goldstein, 1997; Browning and Horton, 2004;
Horton et al., 2002). In addition, impaired b-oxidation due to
mitochondrial dysfunction or carnitine palmitoyl transferase-1
inhibition by malonyl-CoA contributes to the FFA accumulation
and storage as triglycerides (TG) in hepatocytes (Abu-Elheiga
et al., 2000; McGarry et al., 1977).CELL METABOLISM 4, 185–198, SEPTEMBER 2006 ª2006 ELSEVIER INThe accumulation of lipids in the cytoplasm of hepatocytes,
mostly in the form of FFA and TG, is considered the first step
in the development of SH. However, SH progression beyond he-
patic steatosis usually does not occur in the absence of a second
hit that promotes oxidative stress, inflammation, cell death, and
fibrosis. In this regard, cytokine overexpression and their mem-
brane receptors have been shown in both ASH and NASH to
contribute to hepatocellular apoptosis and SH (Angulo, 2002;
Feldstein et al., 2003; Crespo et al., 2001; Iimuro et al., 1997;
Yin et al., 1999). For instance, TNF is overexpressed in the liver
of obese mice and mediates insulin resistance in both diet-
induced and genetic models of obesity (Hotamisligil, 1999; Lin
et al., 2002; Uysal et al., 1997). Furthermore, TNF is required
for the development of fatty liver by alcohol and subsequent
progression to alcohol-induced liver damage (Iimuro et al.,
1997; Yin et al., 1999; Xu et al., 2003), and recent findings using
mice deficient in both TNF receptor 1 and 2 showed a critical
role for TNF signaling in diet-induced NASH (Tomita et al.,
2006). However, in addition to TNF, other cytokines also play
a role in SH. For instance, a stronger expression of the Fas re-
ceptor in hepatocytes has been observed in liver specimens
from patients with both ASH and NASH (Feldstein et al., 2003;
Ribeiro et al., 2004). Moreover, diet associated hepatic steatosis
has been shown to sensitize to Fas-mediated liver injury in mice
(Feldstein et al., 2003b). Thus, understanding the mechanisms
that determine the susceptibility of steatotic hepatocytes to in-
flammatory cytokines (e.g., TNF/Fas) is of relevance as it may
open the prospect for novel therapeutic strategies for ASH
and NASH.
Since FFA, TG, and cholesterol accumulation may coexist in
hepatic steatosis, we wondered whether the type rather than
the amount of fat determines the susceptibility of the fatty liverC. DOI 10.1016/j.cmet.2006.07.006 185
A R T I C L Eto inflammatory cytokine-mediated hepatocellular apoptosis
and SH. Thus, our aim was to address the contribution of indi-
vidual lipids in the susceptibility of fatty liver to TNF and Fas.
Here, using nutritional (feeding a choline-deficient or a hypercho-
lesterolemic diet) and genetic (mice deficient in NPC1, a late
endosomal protein involved in intracellular cholesterol traffick-
ing, and obese ob/ob mice) models of hepatic steatosis, we
show that free cholesterol (FC) accumulation, but not TG and
FFA, sensitizes hepatocytes to TNF- and Fas-induced apopto-
sis and SH development. This outcome was not mediated by
alterations in the apoptotic signaling of TNF, suppression of sur-
vival pathways dependent on NF-kB or induction of ER stress
due to FC loading. Rather, sensitization to TNF was due to FC
accumulation in mitochondria, which resulted in mGSH deple-
tion. Indeed, in vitro mGSH depletion in lean hepatocytes reca-
pitulated the susceptibility seen in FC-loaded hepatocytes,
whereas mGSH repletion in vivo rescued FC-loaded livers
from TNF-induced SH.
Results
Hepatic steatosis with predominant
TG or FC accumulation
In order to examine the contribution of individual lipids in the
transition from steatosis to SH, we fed rats a choline-deficient
(Lombardi) diet or a sodium cholate-supplemented hypercho-
lesterolemic (HC) diet, for 2–14 days. Livers from rats fed the
Lombardi diet for 2 days displayed macrovesicular steatosis,
characterized by increased TG levels both in liver and plasma
(data not shown), while total cholesterol levels remained un-
changed (Figures 1A–1C), as reported previously (Hakamada
et al., 1997). Moreover, the levels of phosphatidylcholine (PC)
in liver homogenates from Lombardi-fed and chow-fed rats
were 41 6 8 and 52 6 6 nmol/mg prot after 2 days of feeding
and 38 6 7 and 46 6 6 nmol/mg prot after 14 days of feeding,
with similar phosphatidylethanolamine (PE) levels (33–38 nmol/
mg prot). Furthermore, the levels of sphingomyelin, phosphati-
dylserine, and phosphatidylinositol in liver homogenates from
Lombardi-fed rats for 2 or 14 days were similar to those of
chow-fed rats (5.2 6 0.6, 3.1 6 0.4, and 10.2 6 1.5 nmol/mg
prot, respectively), with no changes in the fatty acid composition
(data not shown). Hepatic histology and the lipid profile from rats
fed the Lombardi diet supplemented with choline were similar to
those of chow-fed rats (data not shown). In contrast, livers from
HC diet-fed rats for 2 days exhibited microvesicular steatosis
with increased total cholesterol levels in liver and plasma (data
not shown), and unchanged TG content (Figures 1A–1C). He-
patic FFA levels increased to a similar extent in both models
compared to chow-fed rats (Figure 1D). Feeding a cholesterol
enriched diet (2%) for 2 days in the absence of 0.5% sodium
cholate did not increase cholesterol levels (Figure S1 in the Sup-
plemental Data available with this article online), requiring longer
feeding time (6–8 days) for cholesterol accumulation (data not
shown). Furthermore, feeding Lombardi and HC diets increased
hepatic SREBP-1c mRNA levels, while the HC diet increased
acyl CoA:cholesterol acyl transferase (ACAT) mRNA levels.
SREBP-2 and HMGCoA reductase (HMGCoAR) mRNA levels,
however, decreased upon HC diet feeding (Figure S2). Rats
fed the Lombardi diet displayed increased HMGCoAR mRNA
levels (Figure S2). To examine whether this nutritional approach
enhanced hepatic FC levels, we stained cultured hepatocytes186with filipin, a fluorescent polyene antibiotic, which binds specif-
ically to the 3b-hydroxyl group of sterols (Norman et al., 1972)
(Figure 1E). As seen, FC in hepatocytes from chow-fed or Lom-
bardi-fed rats was present mostly in the plasma membrane,
while feeding HC diet markedly increased FC levels in plasma
membrane and in intracellular sites (Figure 1E). Moreover, the
hepatic total cholesterol levels increased gradually over the
14 days of HC diet feeding with FC pool peaking between 1–5
days followed by enhanced cholesteryl ester formation (data
not shown). Finally, we examined the histology, lipid profile,
and mRNA levels in the livers from Lombardi diet-fed rats for 3
days and then switched to the HC diet for 2 days (L-HC), a con-
dition in which TG and FC accumulation coexist. As seen, this
approach resulted in a mixed phenotype with macrovesicular
steatosis, increased TG levels, and FC accumulation and
changes in SREBP1c, SREBP-2, ACAT, and HMGCoAR
mRNA levels (Figures 1A–1E and Figure S2).
FC accumulation sensitizes the liver
to TNF- and Fas-mediated SH
Since inflammatory cytokines promote SH (Angulo, 2002; Feld-
stein and Gores, 2005), we examined the fate of TG- or FC-
loaded hepatocytes in response to TNF and Fas. While hepato-
cytes from Lombardi-fed rats were insensitive to TNF exposure,
TNF was cytotoxic to hepatocytes from HC diet-fed rats, induc-
ing apoptotic and necrotic cell death (Figure 2A). Morevoer, TNF
induced the release of cytochrome c, caspase-3 activation, and
ROS generation in hepatocytes from HC diet-fed rats (Figures
2B–2D). The susceptibility of hepatocytes from HC-fed rats to
TNF was prevented by GSH-EE, vitamin E, or BHT treatment
(data not shown). TNF or LPS are known to induce in vivo lethal
hepatitis after sensitization of the liver with D-galactosamine
(Lehmann et al., 1987; Mari et al., 2004). Thus, we assessed
the in vivo susceptibility of Lombardi or HC diet-fed rats to
LPS challenge. Compared to chow-fed rats, LPS induced mini-
mal liver injury in Lombardi diet-fed rats (Figures 2E–2G), while
causing extensive hemorrhagic lesions, clusters of necrotic he-
patocytes in HC diet-fed rats (Figures 2E–2G), and inflammatory
cell infiltration reflectedbymyeloperoxidase staining (Figure 2H).
Moreover, we tested the effect of a sublethal dose (5 mg/mice,
i.p.) (Feldstein et al., 2003b) of the agonistic anti-Fas antibody
Jo2 to mice fed the Lombardi or the HC diets. As seen, Jo2
caused significant hepatocellular death and apoptosis, release
of serum ALT, and inflammation in HC- or L-HC-fed mice (Fig-
ure 2G) with myeloperoxidase staining (data not shown),
whereas in Lombardi-fed mice the injury was minimal. Similar
findings were observed upon TNF administration (i.v.) to HC-
fed rats (data not shown). Consistent with the time-dependent
pattern of FC loading, the susceptibility to cytokines translated
in hepatocellular death and inflammation is observed after
feeding the HC diet for 1–5 days (data not shown). Furthermore,
steatotic hepatocytes with TG and FC accumulation from L-HC-
fed rats exhibited a similar hepatocellular susceptibility to TNF
in vitro or LPS in vivo as HC-fed rats (Figures 2E–2G). Thus,
the presence of TG does not alter the susceptibility to TNF or
Jo2 caused by FC loading, and this in vivo sensitization contrib-
uted to SH.
Diet-induced FC loading, TNF signaling, and ER stress
We examined whether cholesterol loading perturbed TNF sig-
naling by analyzing the activation of NF-kB and the generationCELL METABOLISM : SEPTEMBER 2006
Mitochondrial cholesterol and steatohepatitisFigure 1. Diet-induced hepatic steatosis
A) Representative hematoxylin and eosin (H&E) (magnification at 103) or Oil Red O-stained 4-micron sections (magnification at 203) of liver sections from chow-,
Lombardi-, or HC-fed rats for 2 days. L-HC animals were fed Lombardi diet for 3 days plus HC diet for 2 days.
B–D)Hepatic cholesterol, TG, and FFA concentrations were measured in liver homogenate from animals fed the different diets for 2 days. All values are expressed asmean
(6 SEM), n = 8–12. *p < 0.05 versus chow-fed group.
E)Representative fluorescencemicroscopy of free cholesterol by filipin (0.05mg/ml) staining of cultured hepatocytes isolated from all groups as described in Experimental
Procedures.of proapoptotic signals that reflect the function of complexes I
and II of TNF receptor 1 (TNFR1) signaling (Micheau and
Tschopp, 2003). The activation of NF-kB, as the nuclear translo-
cation of p65, and caspase 8, bona fide markers of complexes I
and II of TNFR1, respectively, were similar in FC-loaded or lean
hepatocytes, as well as in hepatocytes from Lombardi-fed ratsCELL METABOLISM : SEPTEMBER 2006(Figures S3A and S3B). Further, the TNF-induced JNK phos-
phorylation andmitochondrial Bax translocation, whichmediate
TNF apoptosis, were independent of cholesterol loading (Fig-
ures S3C and S3D).
ER stress is known to regulate apoptotic pathways (Brecken-
ridge et al., 2003), and FC trafficking to the ER in macrophages187
A R T I C L EFigure 2. Sensitization of steatotic hepatocytes to TNF
A) Cell death was determined 16 hr after TNF (100 ng/ml) challenge by double staining with Ho¨echst 33258 (10 mM) and propidium iodide (10 mM) to detect apoptotic and
necrotic cells, respectively. At least 250 cells in six different high-power fields were counted and expressed as a percentage of total cells (mean 6 SD).
B) Cytochrome c release was determined by Western blot 6 hr after TNF challenge in cytosol (spnt) and mitochondria (pellet). b-actin was used as a loading control.
C) 6 hr after TNF treatment, aliquots of cell extracts were prepared for caspase 3 activity using a fluorescent peptide. *p < 0.001 versus chow-fed hepatocytes. The data
represent the mean 6 SEM.
D) ROS were determined 4 hr after TNF challenge in hepatocytes by DCF fluorescence. *p < 0.01 versus chow-fed hepatocytes. The data represent the mean 6 SEM.
E and F) Serum ALT and AST were determined 24 hr after intravenous LPS injection. Mean6 SEM values are shown, n = 8–12 animals per group. *p < 0.001 versus chow-
fed group.188 CELL METABOLISM : SEPTEMBER 2006
Mitochondrial cholesterol and steatohepatitishas been shown to trigger ER stress and activation of the un-
folded protein response (Feng et al., 2003). Thus, we examined
whether diet-induced FC accumulation in the liver caused ER
stress. Hepatocytes from HC-fed rats exhibited colocalization
of filipin with Rab7, a late endosomal marker, and Bip/GRP78,
a resident ER chaperone (Figures S3E and S3F), indicating
that excess FC derived from diet trafficked from late endosomes
to ER. The enrichment of ER in FC observed by filipin staining
was confirmed in isolated ER fraction from HC diet-fed rat liver
(66% 6 7%, p < 0.05) compared to chow control (5.7 6 0.7 mg/
mg protein). Moreover, among the ER-recruited pathways that
contribute to cell death include the activation of caspase-12
and the transcription factor CHOP (Breckenridge et al., 2003;
Feng et al., 2003). Hepatocytes exposed to tunicamycin/brefel-
din A, positive ER stress inducers, exhibited caspase 12 (Fig-
ure S3G) and CHOP activation (Figure S3H). In contrast, the
levels of CHOP, Bip, or calreticulin were similar in hepatocytes
from chow- or HC-fed rats (Figure S3H). In addition, the nuclear
content of ATF-4, a downstream effector of the ER-resident pro-
tein kinase, PERK, was similar in hepatocytes from chow- or
HC-fed rats (data not shown). The extent of caspase-12 activa-
tion by FC loading (less pronounced than that caused by tunica-
mycin/brefeldin A) was insufficient to activate caspase 3 (Fig-
ure 2C) and, more important, unchanged by the presence of
TNF (Figure S3G). Furthermore, since FC loading in ER can
result in ER Ca2+ depletion, we analyzed Ca2+ release from
ER in response to thapsigargin, an inhibitor of ER Ca2+ pump
(Feng et al., 2003). As seen, the release of Ca2+ stores from
ER in response to thapsigargin occurred with similar kinetics
in hepatocytes from chow- or HC-fed rats with or without TNF
exposure (Figure S3I). Together, these findings discard pertur-
bations in the TNF signaling and suggest that ER stress plays
a minor role in the sensitization of cholesterol-loaded hepato-
cytes to TNF.
Diet-induced mitochondrial FC loading depletes mGSH
In addition to the ER, cholesterol also traffics to mitochondria
(Soccio and Breslow, 2004). Increased mitochondrial FC accu-
mulation impairs mitochondrial function (Colell et al., 2003; Lluis
et al., 2003; Rogers et al., 1980; Rouslin et al., 1982; Yu et al.,
2005). Thus, we examined whether the hepatocellular suscepti-
bility to TNF caused by cholesterol accumulation was mediated
by mitochondrial FC trafficking. Electron microscopy and West-
ern blot levels of GRP78, Na+/K+ATPase a1, Rab5A, and Rab11
of isolated mitochondria indicated insignificant contamination
with ER, plasma membrane, and early or recycling endosomes,
respectively, in the final mitochondrial fraction from chow- or
HC-fed rats (Figures 3A and 3B). Furthermore, the presence of
lysosomes, which can participate in cell death pathways, was
minimal as the final mitochondrial fraction was de-enriched in
acid phosphatase (data not shown). Total cholesterol levels in
mitochondria increased gradually only upon HC diet feeding
(Figure 3C), in agreement with previous observations (Rogers
et al., 1980). However, FC content in mitochondria increased
transiently during the first 6 days of HC feeding followed by cho-
lesteryl esters formation (Figure 3D). Furthermore, the distribu-CELL METABOLISM : SEPTEMBER 2006tion of cholesterol esters was 55% 6 5% and 48% 6 7% in
the outer mitochondrial membrane for chow-fed and 1 day
HC-fed rats, respectively and 38% 6 8% and 31% 6 7% in
mitoplasts. To further ensure the accumulation of FC in mito-
chondria by HC feeding, hepatocytes were stained with filipin
and cytochrome c and analyzed by laser confocal microscopy
(Figure 3E). FC colocalized with mitochondria as seen by the
merged fluorescence of filipin/cytochrome c (Figure 3E). More-
over, the pattern of mitochondrial filipin staining in hepatocytes
at day 0 or day 7 after HC feeding was similar (Figure S4), con-
sistent with the free cholesterol content determined biochemi-
cally in purified mitochondria (Figure 3D). Since increased levels
of cholesterol within biological membranes influence their dy-
namic properties (Colell et al., 2003; Gimpl et al., 1997; Rouslin
et al., 1982), we analyzed the changes in the steady-state fluo-
rescence anisotropy of mitochondria bound dyes to monitor
the rotational diffusion freedom of the reported probes with
respect to both the rate and the range or extent of the rotational
motion (Van Blitterswijk et al., 1981). Hepatic mitochondria from
HC-fed rats exhibited higher fluorescence polarization of DPH
and TMA-DPH compared to chow or Lombardi diet feeding
(Figure 3F), indicating decreased membrane fluidity. Because
mGSH plays a critical role in cell defense and TNF susceptibility
(Armstrong and Jones, 2002; Colell et al., 1998; Garcia-Ruiz
et al., 2003; Lluis et al., 2003) and its transport to mitochondria
depends on membrane dynamics (Fernandez-Checa and Ka-
plowitz, 2005), we examined the levels of mGSH. While cytosol
GSH levels were similar in the various dietary groups, mGSH
was selectively depleted in hepatocytes from HC-fed rats
(Figure 3G). Thus, FC loading in mitochondria decreases mito-
chondrial membrane fluidity and mGSH levels.
Mitochondrial FC, mGSH depletion, and TNF
susceptibility in NPC12/2 hepatocytes
We validated the findings in HC-fed rats using another FC load-
ing model. NPC1 is a late endosomal protein involved in the
intracellular transport of cholesterol (Liscum, 2000; Soccio and
Breslow, 2004), and homozygous mutant NPC12/2 mice have
been reported to exhibit enhanced hepatic cholesterol content
(Beltroy et al., 2005; Erickson et al., 2005). Thus, we assessed
the susceptibility of hepatocytes from NPC12/2 mice to TNF in
relation to the hepatic lipid profile. As seen, the hepatic levels
of TG were lower in NPC12/2 hepatocytes with unchanged
FFA content compared to NPC1+/+ cells (Figure 4A). However,
total cholesterol levels increased 8- to 10-fold (Figure 4A), in
agreement with recent observations (Beltroy et al., 2005; Erick-
son et al., 2005). Moreover, hepatocytes from NPC12/2 mice
exhibited increased intracellular FC accumulation indicated by
filipin staining that colocalized with mitochondria (Figure 4B).
The traffic of FC to the ER was defective in NPC12/2 hepato-
cytes (Figure 4C), in agreement with similar findings in macro-
phages from NPC1+/2 mice (Feng et al., 2003), consistent with
the lack of unfolded protein response and ER stress in
NPC12/2 hepatocytes based on the levels of PERK, CHOP,
and ATF-4 (data not shown). However, as expected from the
FC accumulation in hepatocytes (Figure 4B), hepatocytes fromG) Representative H&E slides from rats after the LPS challenge or mice 8 hr after an i.p. injection of Jo2 (5 mg/mouse). H&E-stained sections were photographed on a Zeiss
Axioplan using a Nikon DXM1200F digital camera (magnification at 203). The serum ALT values (IU/L) correspond to the Jo2 treatment, *p < 0.05 versus chow-fed mice.
H) Representative myeloperoxidase staining of liver sections in HC-fed livers challenged with LPS (magnification at 403).189
A R T I C L EFigure 3. Mitochondrial FC accumulation depletes mGSH
A) Western blot of cytochrome c, GRP78/Bip, Na+/K+ATPase a1, Rab5A, and Rab11 in liver homogenates or mitochondrial fraction.
B) Purified mitochondria were fixed and processed for electron microscopy (17,5003).
C and D) Purified rat liver mitochondria were analyzed for the total as well as free and esterified cholesterol content. (C) Total cholesterol from chow (n = 8), HC (n = 12), and
Lombardi (n = 8) animal feeding are shown. The data represent the mean 6 SD. (D) Free and esterified cholesterol levels in mitochondria from HC-fed rats were analyzed
by HPLC and mean 6 SD values are shown.190 CELL METABOLISM : SEPTEMBER 2006
Mitochondrial cholesterol and steatohepatitisFigure 4. Hepatocytes from NPC12/2 mice exhibit
mitochondrial FC loading and mGSH depletion
A) Hepatic cholesterol, TG, and FFA concentrations
were measured in liver homogenates. All values are
expressed as mean (6 SEM), n = 5. *p < 0.05 versus
chow-fed group.
B and C) Mouse hepatocytes from wild-type or
NPC12/2mice were isolated and stained with filipin,
mouse anti-cytochrome c, or rabbit anti-Bip/GRP78
followed by the appropriate secondary antibodies.
Experiments shown are representative confocal im-
ages of three to four different experiments.
D) Cell death was determined by double staining
with Ho¨echst 33258 (10 mM) and propidium iodide
(10 mM) to detect apoptotic and necrotic cells, re-
spectively. Values are expressed as mean 6 SD of
at least three experiments. *p < 0.01 versus control
WT hepatocytes.
E) compartmentalized GSH from freshly isolated WT
and NPC12/2 hepatocytes were analyzed by HPLC
as described in Experimental Procedures. Results
are mean 6 SD of at least three experiments. *p <
0.01 versus WT hepatocytes.NPC12/2 mice exhibited mGSH depletion and susceptibility to
TNF (Figures 4D and 4E). Thus these data further confirms the
critical role of mitochondrial FC loading in the hepatocellular
sensitization to TNF in the absence of increased TG and FFA
accumulation.
Hepatocellular TNF sensitization
and SH occur if mGSH is low
Next we assessed the causal role of mGSH depletion in the he-
patocellular susceptibility to TNF and asked whether mGSH de-
pletion recapitulates the findings of mitochondrial FC loading.
We used 3-hydroxy-4-pentenoate (HP) to selectively deplete
mGSH pool due to its biotransformation into a Michael electro-
phyle, which is then conjugated with GSH in the mitochondrial
matrix (Shan et al., 1993; Colell et al., 1998; Garcia-Ruiz et al.,
2003). As seen, HP-treated hepatocytes exhibited selective
mGSH depletion (Figure 5A), with spared cytosol GSH stores.
Compared to the resistance of control hepatocytes to TNF,
HP treatment sensitized hepatocytes to TNF by a mechanism
dependent on caspase-8 activation and oxidative stress
(Figure 5B). In addition, mGSH-depleted hepatocytes by HP ex-
hibited enhanced susceptibility to Jo2-mediated cell death
compared to untreated cells (28% 6 6% cell death in mGSH-CELL METABOLISM : SEPTEMBER 2006repleted cells and 87% 6 8% cell death in mGSH-depleted he-
patocytes, p < 0.05). The overgeneration of ROS required both
mGSH depletion by HP and TNF, and GSH repletion by the per-
meable form of GSH, GSH-EE, prevented TNF-induced ROS
generation (Figure 5C). Consistent with previous findings on
the critical role of acidic sphingomyelinase (ASMase) in TNF-
induced hepatocellular apoptosis (Garcia-Ruiz et al., 2003;
Osawa et al., 2005), ASMase was necessary for TNF-induced
ROS overgeneration (Figure 5D) and cell death (Figure 5E). Fur-
thermore, since NF-kB has been shown to inhibit TNF-induced
apoptosis by suppressing ROS (Kamata et al., 2005; Pham
et al., 2004), we examined whether mGSH depletion abrogated
TNF-induced NF-kB activation. As seen, the kinetics of NF-kB
activation by TNF and subsequent gene expression were not af-
fected by mGSH depletion (Figures 5F and 5G). These findings
indicate that mGSH determines the hepatocellular susceptibility
to TNF through control of mitochondrial ROS stimulation and not
by disabling NF-kB-dependent survival pathway.
Furthermore, S-adenosyl-L-methionine (SAM) therapy, which
has been shown to fluidize mitochondrial membranes and re-
store mGSH (Colell et al., 1997; Mari et al., 2004), protected
HC-fed rat liver from LPS compared to untreated HC-fed rats,
and this effect was accompanied with higher mGSH levelsE) Hepatocytes from chow- or HC-fed rats for 1 day were isolated to examine the colocalization of mitochondria and FC by confocal microscopy using mouse anti-cyto-
chrome c Ab and filipin, respectively.
F) Purified rat liver mitochondria were labeled with DPH or TMA-DPH and fluorescence anisotropy was monitored at 366 nm (emission = 440 nm) using polarizing filters in
both excitation and emission planes and normalized per mg of mitochondrial protein. Mean 6 SD values from 4 rats/group are shown. *p < 0.01 versus chow-fed group.
G) Compartmentalized GSH from freshly isolated hepatocytes from the various groups were analyzed by HPLC as described in Experimental Procedures. Values are
expressed as mean 6 SD, n = 12 rats/group. *p < 0.001 versus control hepatocytes.191
A R T I C L EFigure 5. mGSH depletion in vitro by HP sensitizes
hepatocytes to TNF
A) GSH compartmentalization in cytosol and mito-
chondria from hepatocytes treated with HP (0.5 mM)
for 5 min. Results are expressed as mean 6 SD of
at least six experiments. *p < 0.01 versus untreated
hepatocytes.
B) Control or HP-treated mouse hepatocytes were
exposed to TNF for 16 hr with or without caspase 8
inhibitor, BHT, or vitamin E, as described in Experi-
mental Procedures. Cell death was determined as
in Figure 2A. At least 250 cells in six different high-
power fields were counted and expressed as a per-
centage of total cells (mean 6 SD). *p < 0.01 versus
control.
C) ROS were monitored over time after TNF chal-
lenge in hepatocytes. Results are mean 6 SD of
four experiments. *p < 0.01 versus control.
D) ROS were determined 4 hr after TNF challenge in
hepatocytes isolated fromwild-type and ASMase2/2
mice. The data represent the mean 6 SD.
E) ASMase2/2mouse hepatocytes were exposed to
TNF for 16 hr after mGSH depletion by HP. Cell death
was determined as in panel (B). The data represent
the mean 6 SD.
F) Representative NF-kB mobility shift assay using
nuclear extracts from hepatocytes after TNF
exposure.
G) Representative RT-PCR of iNOS and cIAP1, as
described in Experimental Procedures.(Figure 6). The recovery of mGSH occurred between 4–6 hr after
SAM treatment (data not shown), suggesting that mGSH nor-
malization protected against LPS-induced SH.
Mitochondrial FC in ASH and NASH
and effect of atorvastatin
Wenext addressed the relevance of these findings in the context
of ASH and NASH. Prior evidence using models of alcohol-in-
duced liver damage or HepG2 cells exposed to acetaldehyde
showed FC accumulation, mGSH depletion, and hepatocellular
susceptibility to TNF (Colell et al., 1997, 1998; Lluis et al.,
2003).Moreover, lovastatin pretreatment, which abolishedmito-
chondrial FC accumulation, protected acetaldehyde-exposed
HepG2 cells fromTNF-induced death throughmGSHnormaliza-
tion (Lluis et al., 2003). In contrast to the data in ASH, the role of
FC in mitochondria in NASH has not been previously examined.192Thus, we analyzed the regulation of FC and mGSH in hepato-
cytes from obese ob/obmice. Compared to leanmice, the livers
of ob/obmice had enhanced levels of TG, FFA, and total choles-
terol (data not shown). The levels of FC were higher in hepato-
cytes from ob/ob mice, which colocalized with cytochrome c
and Bip/GRP78 (Figures 7A and 7B). As expected from themito-
chondrial FC loading, mGSH was depleted in hepatocytes from
ob/ob mice with respect to lean mice, whereas the cytosol GSH
content remained unchanged (Figure 7C), in agreement with re-
cent findings (Robin et al., 2005). Finally, we examined the ther-
apeutic efficacy of atorvastatin in the regulation of mitochondrial
FC loading, mGSH homeostasis and susceptibility to LPS. Ator-
vastatin therapy toob/obmiceprevented theaccumulationof FC
in mitochondria that translated in the normalization of themGSH
pool (Figures 7A and 7C) and restoration of mitochondrial mem-
brane fluidity (data not shown). Moreover, consistent with theseCELL METABOLISM : SEPTEMBER 2006
Mitochondrial cholesterol and steatohepatitisFigure 6. SAM prevents LPS-induced NASH
A) Representative H&E staining of liver samples from
HC-fed rats 24 hr after LPS injection plus or minus
SAM treatment.
B) Serum ALT and AST 24 hr after intravenous LPS
injection plus or minus SAM in HC-fed animals. The
data represent the mean 6 SEM.
C)GSH levels in mitochondria isolated from chow- or
HC-fed rats for 1 day and then treated with LPS plus
or minus SAM for 24 hr. Results are expressed as
Mean 6 SEM, n = 8–12 animals per group. *p <
0.01 versus chow group. **p < 0.05 versus HC+LPS
group.findings, atorvastatin ameliorated the basal signs of SH and pre-
vented the susceptibility of ob/ob mice to LPS-mediated liver
injury and inflammation (Figures 7D and 7E). Moreover, atorvas-
tatin treatment did not affect the serum TNF levels upon LPS
challenge (2170 6 180 pg/ml versus 1997 6 210 pg/ml 90 min
after an i.v. injectionof LPS in ob/obmicewith orwithout atorvas-
tatin therapy, respectively). Thus, these data support a potential
therapeutic role of statins in NASH development.
Discussion
Discriminating the susceptibility of fatty
liver to TNF- and Fas-mediated SH
Weused nutritional and genetic models of hepatic steatosis with
predominant TG, FFA, and FC accumulation to address whether
the type rather than the amount of fat determines the hepatocel-
lular susceptibility to TNF and Fas, which have been shown to
contribute to SH (Angulo, 2002; Crespo et al., 2001; Feldstein
et al., 2003, 2003b; Ribeiro et al., 2004; Tilg and Diehl, 2000;
Tomita et al., 2006). Indeed, defective TNF signaling through
both TNF receptor 1 and 2 results in amelioration (but not in pre-
vention) of SH induced by a methionine- and choline-deficient
diet (Tomita et al., 2006).
By feeding a HC diet or usingNPC12/2mice, we show that FC
but not TG or FFA accumulation sensitizes to TNF- and Fas-in-
duced hepatocellular death and inflammation. Previous studies
suggested a role for FFA in SH progression and susceptibility
to Fas-mediated hepatocellular apoptosis and inflammationCELL METABOLISM : SEPTEMBER 2006(Feldstein et al., 2003, 2003b). However, the role of FFA in this
study appears to be minor. First, the accumulation of FFA ob-
served in Lombardi or HC-fed rats was similar with comparable
saturated to unsaturated fatty acids profiles in both cases. Sec-
ond, NPC12/2 deficiency resulted in selective cholesterol accu-
mulation with unchanged FFA levels and decreased TG content.
Furthermore, in addition to causing hepatic TG accumulation
through impaired plasma VLDL secretion, choline deficiency
may affect PC synthesis via the CDP-choline pathway. How-
ever, the levels of PC in the livers from Lombardi-fed rats were
not decreased with respect to those of choline supplemented
or chow-fed controls, in agreement with recent observations
(Kulinski et al., 2004). In contrast to studies in which choline de-
ficiencywas induced alongwithmethionine deprivation, the lack
of choline by itself does not seem to limit the synthesis of PC due
to the activation of CTP:phosphocholine cytidyltransferase and
availability of phosphorylcholine above the Km for the cytidyl-
transferase (Kulinski et al., 2004). Consistent with this outcome,
choline deficiency did not alter the PC/PE ratio, which has been
shown to be a critical determinant of SH progression through
maintenance of membrane integrity (Li et al., 2006). Moreover,
the nuclear translocation of p65, reflecting the activation of
NF-kB, or the cleavage of procaspase 8 by TNFwere unaffected
by Lombardi diet feeding, suggesting that choline deficiency did
not perturb TNF signaling. Thus, although choline deficiency
reproduces the TG/FFA accumulation and macrovesicular stea-
tosis observed in liver specimens from morbidly obese subjects
and patients with alcoholic liver injury (Mavrelis et al., 1983),193
A R T I C L EFigure 7. Cholesterol in ob/ob mice and atorvastatin therapy
A and B)Mouse hepatocytes from wild-type or ob/ob mice were isolated and stained with filipin, mouse anti-cytochrome c, or (B) rabbit anti-Bip/GRP78 followed by the
appropriate secondary antibodies. Experiments shown are representative confocal images of three to four different experiments performed.
C) GSH in cytosol and mitochondria from chow or ob/ob hepatocytes. Results are expressed as mean 6 SD of at least three experiments.
D)SerumALT and AST levels in ob/ob or leanmice following or not atorvastatin (Atorv) therapy and/or LPS challenge. Data aremean6SEM. n = 6mice per group. *p < 0.05
versus untreated ob/ob mice; #p < 0.05 versus atorvastatin-treated ob/ob mice; **p < 0.05 versus LPS-treated ob/ob mice.
E) Representative H&E images from ob/ob mice after atorvastatin therapy or not and/or LPS challenge (magnification at 203).194 CELL METABOLISM : SEPTEMBER 2006
Mitochondrial cholesterol and steatohepatitisthese metabolic disturbances are not sufficient for the progres-
sion to SH nor for the hepatocellular susceptibility to TNF/Fas,
invoking the requirement for additional factors.
Using NPC12/2mice, we show that FC accumulates in hepa-
tocytes in agreement with the observations of extensive unes-
terified cholesterol storage in the liver of NPC12/2 mice (Erick-
son et al., 2005). Furthermore, we find in both HC-fed rats and
NPC12/2 mice that FC accumulates in mitochondria, as previ-
ously reported in the livers from rats fed a cholesterol-enriched
diet (Rogers et al., 1980) or in the brain from NPC12/2 mice (Yu
et al., 2005). In contrast, FC accumulation in the ER occurs in
HC-fed rats as determined in isolated microsomal preparations,
but not in hepatocytes fromNPC12/2mice, in concordance with
previous observations in cholesterol-loaded macrophages from
NPC1+/2 mice (Feng et al., 2003), thus discarding a role for ER
stress in contributing to the sensitization to inflammatory cyto-
kines-mediated SH. If the ER FC loading were involved in the he-
patocellular susceptibility to TNF, we would expect hepatocytes
deficient in NPC1 to be resistant to TNF. Unexpectedly,NPC12/2
hepatocytes exhibited an intrinsic susceptibility to TNF, similar
to hepatocytes from HC-fed rat liver. Thus, our findings are con-
sistent with the two hits hypothesis, indicating that mitochon-
drial FC loading but not TG or FFA plays a role as a first hit in
the progression of fatty liver disease to SH through sensitization
to TNF or Fas.
mGSH depletion and hepatocellular sensitivity to TNF
Our findings reveal the selective depletion of mGSH in both HC-
fed rats and NPC12/2 mice due to FC loading in mitochondria.
Indeed, the mitochondrial transport of GSH is highly sensitive
to membrane dynamics and normalization of the mitochondrial
membrane fluidity restored the mitochondrial transport of GSH
and mGSH levels in cholesterol-enriched mitochondria (Colell
et al., 1997; Fernandez-Checa and Kaplowitz, 2005; Lluis et al.,
2003). The selective mGSH depletion by HP in normal hepato-
cytes recapitulated the susceptibility to TNF or Jo2 seen in the
HC feeding model or in NPC12/2 mice. The question is then:
how or why does mGSH determine the hepatocellular suscepti-
bility to TNF?Theapoptotic signalingof TNF is complex involving
protein-protein interactions and recruitment of signaling media-
tors that converge on mitochondria that stimulate mitochondrial
membrane permeabilization, cytochrome c release, and cas-
pase activation (Bradham et al., 1998; Micheau and Tschopp,
2003). Simultaneously to these death-promoting pathways,
TNF activates survival pathways dependent on NF-kB (Kamata
et al., 2005; Pham et al., 2004). Our previous studies demon-
strated that mGSH depletion with HP enabled TNF to induce cy-
tochrome c release and caspase-3 activation, effects that were
preceded by ROS stimulation and prevented by cyclosporin A
(Garcia-Ruiz et al., 2003). In addition, we show here that the sen-
sitization of hepatocytes to TNF due to selective mGSH deple-
tion by HP is abrogated by inhibition of caspase 8 and antioxi-
dants. Moreover, our data reveal the requirement of ASMase in
TNF-induced oxidative stress and apoptosis in mGSH-depleted
hepatocytes, indicating that the mitochondrial ROS generation
triggered by TNF and subsequent cell death are dependent on
ASMase. Intriguingly, our findings indicate that the sensitization
of hepatocytes to TNF by mGSH depletion is not due to NF-kB
inactivation,whichhasbeen shown to suppressROSovergener-
ation and TNF-induced apoptosis (Pham et al., 2004). While
enhanced NF-kB DNA binding by TNF occurs early (15–30 min),CELL METABOLISM : SEPTEMBER 2006kB-dependent induction of survival genes may take extra time
(hours). In contrast, the ROS generation by TNF in mGSH-de-
pleted hepatocytes occurs very quickly (15–30 min), preceding
the upregulation of NF-kB-dependent survival proteins.
FC, mGSH, and NASH
Previous studies reported that alcohol feeding results in mGSH
depletion and susceptibility to TNF (Colell et al., 1997, 1998;
Wheeler et al., 2001). We extended these observations in
NASH, showing mitochondrial FC accumulation, mGSH deple-
tion, and susceptibility to LPS in ob/ob mice. Of relevance, the
treatment of ob/ob mice with atorvastatin prevented the FC
accumulation in mitochondria and the subsequent mGSH de-
pletion, thus abolishing the susceptibility to LPS-induced liver
damage, similar to the findings observed in HC-fed rats treated
with SAM. Unlike other statins, the active hydroxymetabolites of
atorvastatin, particularly the o-hydroxy derivative, exhibit the
same enzymatic inhibition of HMGCoA reductase as the paren-
tal statin. In addition, the active o-hydroxy derivative of atorvas-
tatin has been described to prevent cholesterol domain forma-
tion by an antioxidant mechanism (Mason et al., 2006).
Whether the antioxidant property of this derivative relates to
its ability to replenish mGSH levels remains to be established.
Enhanced TNF generation in ob/ob mice contributes to NASH
as its downregulation by anti TNF antibodies or probiotic ther-
apy has been shown to improve NASH in this model (Li et al.,
2003). Recent findings have shown the autoamplification of
TNF as a potential mechanism for maintenance of elevated
TNF levels (Neels et al., 2006). Hence, the combination of TNF
overproduction and mGSH depletion that occur in ob/ob mice
are both necessary for SH development. Interestingly, we ob-
served that while atorvastatin corrected the mGSH depletion
in ob/ob mice by preventing the mitochondrial FC enrichment,
it did not change the TNF overproduction. Because FC accumu-
lation does not perturb TNF signaling as shown in the HC-fed
model, the role of FC in promoting TNF sensitization and hence
NASH in obese ob/ob mice seems to be mediated through
mGSH depletion. The efficacy of atorvastatin in ob/ob mice
may further stimulate future clinical studies with statins in pa-
tients with NASH.
In conclusion, our findings are consistent with the two-hits hy-
pothesis, with FC accumulation but not TG or FFA playing a key
role as a first hit because it sensitizes to inflammatory cytokines-
mediated SH throughmGSH depletion. Moreover, although TG-
loaded livers are resistant to TNF, macrovesicular steatosis and
TGmay still contribute to NASH development as they can cause
hepatic inflammation through NF-kB activation with subsequent
TNF generation and adipocytokine unbalance (Cai et al., 2005;
Furukawa et al., 2004; Xu et al., 2003). Thus, our findings reveal
an unrecognized role of FC in SH and suggest that statins or
mGSH-repleting agents may have a niche in the therapeutic
armamentarium for SH.
Experimental procedures
Models of hepatic steatosis
Animal studieswere approved by the IDIBAPSAnimal Care andUseCommit-
tee. Male Sprague-Dawley rats (250 g) were fed a choline-deficient methio-
nine sufficient Lombardi diet (Dyets Inc) or its corresponding choline-supple-
mented control diet, or a hypercholesterolemic diet containing 2% purified
cholesterol with or without 0.5% sodium cholate supplementation (Dyets
Inc.). NPC12/2 and ob/ob mice (both in the C57BL/6 background) were195
A R T I C L Eobtained from The Jackson Laboratories. ASMase2/2mice were maintained
and used as previously described (Garcia-Ruiz et al., 2003; Mari et al., 2004).
Hepatocyte isolation and mitochondria and microsomal preparation
Hepatocytes were isolated and cultured as described (Garcia-Ruiz et al.,
2003; Mari et al., 2004). Rat or mouse hepatocytes were incubated with re-
combinant human TNF-a (15–280 ng/ml; Peprotech EC). Some cultures
were pretreated with the caspase-8 inhibitor Ac-IETD-CHO (50 mM), vitamin
E (50 mM), butylated hydroxytoluene (BHT) (100 mM), or GSH-EE (5 mM). For
the induction of ER stress, hepatocytes were incubated with tunicamycin (5
mg/ml) plus brefeldin A (10 mg/ml) for 24 hr.
Rat liver mitochondria were isolated by differential centrifugation. Alterna-
tively highly purified mitochondria were prepared by rapid centrifugation
through Percoll density gradient as described previously (Colell et al.,
2003). Mitochondrial enrichment was ascertained by the specific activity of
succinic dehydrogenase, while contamination by ER, plasma membrane,
early and recycling endosomes was evaluated by Bip/GRP78, Na+/K+
ATPase a1, Rab5A and Rab11 levels, respectively. In addition, acid phos-
phatase activity monitored the contamination with lysosomes. Mitochondrial
integrity was determined by the acceptor control ratio as the ADP-stimulated
oxygen consumption over its absence using a Clark oxygen electrode with
glutamate/malate or succinate as substrates for respiratory sites for com-
plexes I or II. In some instances, mitochondria were fractionated by digitonin
treatment to prepare outer mitochondrial membrane and mitoplasts as de-
scribed previously (Colell et al., 2003). The efficiency of the procedure was
verified bymonitoring themonoamine oxidase activity in the low-speed pellet
(mitoplasts) compared with the high-speed pellet (outer membrane) or intact
mitochondria from the oxidation of benzylamine (3.3 mM final concentration).
Hepatic ER fraction was isolated from liver homogenates as described
(Ernster et al., 1962) and washed in 0.1 M phosphate buffer (pH 7.2). The
activities of glucose-6-phosphatase and succinic dehydrogenase were
determined to monitor ER enrichment and purity.
Western blot analyses
Cells were lysed with ice-cold RIPA buffer (13 PBS, 1% NP40, 0.5% sodium
deoxycholate, 0.1% SDS), containing 100 mg/mL PMSF and 13 Protease
Inhibitor Cocktail Set III (Calbiochem). After centrifugation at 14,000 3 g for
30 min, proteins in the supernatants were quantified by the Bradford method
(Bio-Rad). Cytosolic, mitochondrial, and nuclear fractions were prepared as
previously described (Garcia-Ruiz et al., 2003).
Western Blot analyses were performed using 20–50 mg of protein/lane in
12% denatured polyacrylamide gel and electrophoresed on a nitrocellulose
membrane for detection by primary and secondary antibodies. Membranes
were incubated with goat polyclonal antibody against Bip/GRP78, rabbit
polyclonal anti-caspase 8, goat polyclonal anti-NFkB-p65, mouse monoclo-
nal anti-CHOP/GADD153, rabbit polyclonal anti-b-actin, rabbit polyclonal
anti-calreticulin, rabbit polyclonal anti-Rab5A, mouse monoclonal anti-
Na+K+-ATPase a1 (Santa Cruz Biotechnology), rat monoclonal anti-cas-
pase-12, mouse monoclonal anti-Bax (clone 5B7) (Sigma), mouse monoclo-
nal anti-cytochrome c (clone 6H2.B4; BD Pharmingen), mouse monoclonal
anti-Phospho-SAPK/JNK, rabbit polyclonal anti-SAPK/JNK (Cell Signaling
Technology), and rabbit polyclonal anti-Rab11 (Zymed). After the incubation
with primary antibody, the membrane was washed and incubated with
peroxidase-conjugated secondary antibodies (1:5000 dilution; Amersham-
Pharmacia), and bound antibody was visualized with ECL detection on
Kodak X-OMAT film (Eastman Kodak).
Laser confocal imaging
Cultured rat hepatocytes were fixed for 10 min in 3.7% paraformaldehyde
in 0.1 M phosphate buffer prior to permeabilization with 0.1% saponin in
0.5% bovine serum albumin/PBS buffer for 5 min. Cells were incubated for
2 hr with 50 mg/ml filipin, rinsed with PBS-0.0025% saponin, followed by in-
cubationwith primary antibodies,mouse anti-cytochrome c antibody (1:500),
goat anti-Rab7 polyclonal antibody (1/50), goat polyclonal antibody against
Bip/GRP78 (1/50), rinsed with PBS-0.0025% saponin, and incubated for
45 min with secondary antibodies. All steps after the addition of filipin were
performed in the dark. After final washes in PBS, cells were mounted and
confocal images were collected using a Leica SP2 laser scanning confocal
microscope equipped with UV excitation, an argon laser, a 633/1.32 OIL
PH3 CS objective and a confocal pinhole set at 1 Airy unit. All the confocal196images shown were single optical sections. Based on the pinhole diameter
and instrument settings, the empirical determination of the slice thickness
was 479 nm. The number of cells observed per field was at least 70–100
per condition.
Assessment of cell death, liver injury, and myeloperoxidase staining
Hepatocellular cell death following TNF challenge was determined by stain-
ing with propidium iodide and Ho¨echst 33258 as described previously (Gar-
cia-Ruiz et al., 2003). Caspase 3 activation from hepatocellular lysates was
determined as described (Mari et al., 2004). Liver samples following LPS or
Jo2 administration were processed for H&E and myeloperoxidase staining
using standard procedures (Servicio Anatomı´a Patolo´gica, Hospital Clinic).
In vivo LPS-induced steatohepatitis and SAM treatment
Animals were fed the different diets overnight and LPS (5mg/kg) was given at
8:00 AM next day intravenously, and 3 hr later, SAM was administered (i.p.,
15mg/kg). Animals were sacrificed 24 hr after LPS injection, for histology and
serum ALT/AST determinations.
Atorvastatin therapy in ob/ob mice
Male ob/ob and lean mice at 6 weeks of age were maintained under specific
pathogen-free condition with controlled temperature and humidity on a 12 hr
light-dark cycle. Autoclaved food and water were provided ad libitum. After a
7 day acclimation period, all mice were divided into groups that received
either vehicle control (nonpyrogenic water) or atorvastatin. Animals were
dosed daily via oral gavage with atorvastatin (10 mg/kg) or vehicle. After 15
days of dosing, mice were killed, and blood and livers were processed for
biochemical determinations, TNFmeasurements, and histology. 24 hr before
killing, some mice received an injection intraperitoneally of LPS (0.3 mg/kg).
Statistical analyses
Experiments were performed routinely with at least 4–6 animals per group.
Representative data from Western blot or confocal microcopy analyses is
shown from at least three independent observations. Statistical comparison
of the mean values was performed using Student’s t test for unpaired data.
Supplemental data
Supplemental data include Supplemental Experimental Procedures, Supple-
mental References, and four figures and can be found with this article online
at http://www.cellmetabolism.org/cgi/content/full/4/3/185/DC1/.
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